Description of the Copper Concentration in Breast Milk in Women Treated for Wilson's Disease
Recruiting
N/A
Interventional Study
Wilson's Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 20 (estimated)
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild · Research network
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Wilson's disease is a rare genetic disease, affecting less than 1,500 people in France. The transmission is autosomal recessive linked to an anomaly of the ATP7B gene on chromosome.This gene codes for an ATPase-type transmembrane protein involved in the transport of copper through the cell plasma member.This gene codes for an ATPase-type transmembrane protein involved in the transport of copper th…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Criteria for inclusion :
* Patient aged 18 years or over.
* Wilson's disease fulfilling the criteria for the Leipzig score
* Pregnancy in progress whatever the term.
* Express consent to participate in the study.
* Affiliate or beneficiary of a social security system.
Criteria for non-inclusion :
…
Contacts
Mickael Alexandre OBADIA
01 48 03 62 52
CONTACT